Cargando…
Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages
A colloidal synthesis’ proof-of-concept based on the Bligh–Dyer emulsion inversion method was designed for integrating into lipid nanoparticles (LNPs) cell-permeating DNA antisense oligonucleotides (ASOs), also known as GapmeRs (GRs), for mRNA interference. The GR@LNPs were formulated to target brai...
Autores principales: | Calero, Macarena, Moleiro, Lara H., Sayd, Aline, Dorca, Yeray, Miquel-Rio, Lluis, Paz, Verónica, Robledo-Montaña, Javier, Enciso, Eduardo, Acción, Fernando, Herráez-Aguilar, Diego, Hellweg, Thomas, Sánchez, Luis, Bortolozzi, Analía, Leza, Juan C., García-Bueno, Borja, Monroy, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671215/ https://www.ncbi.nlm.nih.gov/pubmed/36406277 http://dx.doi.org/10.3389/fmolb.2022.887678 |
Ejemplares similares
-
Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
por: Pavia-Collado, Rubén, et al.
Publicado: (2022) -
Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs
por: Vargas-Caraveo, Alejandra, et al.
Publicado: (2020) -
Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018) -
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)